Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Irregular heartbeat drug 'cuts stroke risk'

  • Comment

A new drug for treating people with an irregular heartbeat has fewer side effects than the standard treatment and is just as good at cutting the risk of stroke, according to new research.

Rivaroxaban, which is easier for people to take, is as effective as warfarin at preventing blood clots and thus lowering the risk of stroke for patients with atrial fibrillation.

The findings published in the New England Journal of Medicine were made by researchers based at the University of Edinburgh and the Duke University in North Carolina.

It has been estimated that about 800,000 Britons have irregular heartbeats. The risk of stroke can be four to six times higher in people suffering from the condition

The study, which involved 14,000 patients, compared the effects of warfarin - the standard drug that prevents clotting in people with irregular heartbeats - with rivaroxaban.

The occurrence of bleeding was similar for both drugs but it was found that the risk of fatal bleeding on the brain was more than halved - from five per 1,000 to two per 1,000 in patients taking rivaroxaban.

 

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs